Inactivation of glycogen synthase kinase-3 beta by phosphorylation: new kinase connections in insulin and growth-factor signalling
about
DIX domains of Dvl and axin are necessary for protein interactions and their ability to regulate beta-catenin stabilityLithium: the pharmacodynamic actions of the amazing ionPhosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase ARegulation of the Akt/Glycogen synthase kinase-3 axis by insulin-like growth factor-II via activation of the human insulin receptor isoform-AFurther evidence that the inhibition of glycogen synthase kinase-3beta by IGF-1 is mediated by PDK1/PKB-induced phosphorylation of Ser-9 and not by dephosphorylation of Tyr-216Oncogenic function of DACT1 in colon cancer through the regulation of β-cateninAxin negatively affects tau phosphorylation by glycogen synthase kinase 3betaRSK3 encodes a novel pp90rsk isoform with a unique N-terminal sequence: growth factor-stimulated kinase function and nuclear translocationMitogen inactivation of glycogen synthase kinase-3 beta in intact cells via serine 9 phosphorylationProtein kinase A enhances, whereas glycogen synthase kinase-3 beta inhibits, the activity of the exon 2-encoded transactivator domain of heterogeneous nuclear ribonucleoprotein D in a hierarchical fashionDirect, activating interaction between glycogen synthase kinase-3beta and p53 after DNA damageActivation of protein synthesis in cardiomyocytes by the hypertrophic agent phenylephrine requires the activation of ERK and involves phosphorylation of tuberous sclerosis complex 2 (TSC2)Evidence that the dephosphorylation of Ser(535) in the epsilon-subunit of eukaryotic initiation factor (eIF) 2B is insufficient for the activation of eIF2B by insulinConvergence of multiple signaling cascades at glycogen synthase kinase 3: Edg receptor-mediated phosphorylation and inactivation by lysophosphatidic acid through a protein kinase C-dependent intracellular pathway.FGF19 as a postprandial, insulin-independent activator of hepatic protein and glycogen synthesisA molecular mechanism for the effect of lithium on developmentActivation and function of the MAPKs and their substrates, the MAPK-activated protein kinasesLife with a single isoform of Akt: mice lacking Akt2 and Akt3 are viable but display impaired glucose homeostasis and growth deficienciesThe protein phosphatase-1/inhibitor-2 complex differentially regulates GSK3 dephosphorylation and increases sarcoplasmic/endoplasmic reticulum calcium ATPase 2 levelsDistinct priming kinases contribute to differential regulation of collapsin response mediator proteins by glycogen synthase kinase-3 in vivoGlycogen synthase kinase-3 regulates IGFBP-1 gene transcription through the thymine-rich insulin response elementAntidepressant mechanism of ketamine: perspective from preclinical studiesReview of pharmacological treatment in mood disorders and future directions for drug development.GSK-3 as potential target for therapeutic intervention in cancerMitotic and mitogenic Wnt signallingRoles of vascular and metabolic components in cognitive dysfunction of Alzheimer disease: short- and long-term modification by non-genetic risk factorsTungstate reduces the expression of gluconeogenic enzymes in STZ ratsCrystal structures of the N-terminal kinase domain of human RSK1 bound to three different ligands: Implications for the design of RSK1 specific inhibitorsA GSK3-binding peptide from FRAT1 selectively inhibits the GSK3-catalysed phosphorylation of axin and beta-cateninA-kinase anchoring protein AKAP220 binds to glycogen synthase kinase-3beta (GSK-3beta ) and mediates protein kinase A-dependent inhibition of GSK-3betaMood stabilizers, glycogen synthase kinase-3beta and cell survivalCoupling of mammalian target of rapamycin with phosphoinositide 3-kinase signaling pathway regulates protein phosphatase 2A- and glycogen synthase kinase-3 -dependent phosphorylation of TauFRAT-2 preferentially increases glycogen synthase kinase 3 beta-mediated phosphorylation of primed sites, which results in enhanced tau phosphorylationNegative regulation of T cell proliferation and interleukin 2 production by the serine threonine kinase GSK-3Specificity and mechanism of action of some commonly used protein kinase inhibitorsProtein phosphatase 2A and its B56 regulatory subunit inhibit Wnt signaling in XenopusProapoptotic stimuli induce nuclear accumulation of glycogen synthase kinase-3 betaLight and electron microscopy study of glycogen synthase kinase-3beta in the mouse brainA New alpha5beta1 integrin-dependent survival pathway through GSK3beta activation in leukemic cellsInvolvement of the glycogen synthase kinase-3 signaling pathway in TBI pathology and neurocognitive outcome
P2860
Q22010042-5929772E-9079-4267-BB7E-EF25BD5A6644Q22241779-5F7066F2-8651-467D-A2B3-3DA518666298Q24290420-5B12EE60-AC0A-4B9C-BCFC-C3F030F063B2Q24291556-D34892B8-AE08-48CF-B7C6-84163B489780Q24309035-AE65A5CA-9390-4773-9FE2-A85F5956C2D6Q24311321-41EFD727-4EEA-49FC-AD97-596FC3F64DD0Q24317033-1E464C67-9449-4B93-B6FF-B15369B5601CQ24320064-90F6C740-6576-4399-BC5D-A9BFF50BDBEFQ24528506-1FCB247D-32B7-4A84-9E9A-499237D46E0BQ24534031-5CB17869-E7A2-4E5A-9C49-A8852F172CDFQ24534352-D360B6A3-BA43-4979-8C6F-1516988EA731Q24534560-7B971139-857E-4948-9ED2-453D585D7237Q24534665-3AA52A60-AC5B-4B87-A5E2-74DB35BC6B8AQ24537174-65A35916-E1AC-4DB5-8C68-7A3D51F30FE9Q24617480-76FD2C07-EF93-4E1D-A60B-4A43C340A144Q24629067-CF83DB5B-BB1B-4017-9A7C-1D14A77F1F7AQ24632768-F2808379-BE33-492C-BD3D-9247A5D3BF06Q24672400-F8CA46BE-89E2-4F3F-8B8C-828FE7518867Q24678277-B7C63433-43D7-4E28-BDEF-7C4488169BC3Q24685647-1A389061-2863-412A-9A7A-15644DFB9554Q24793511-57D217AA-0C49-4105-9A31-722FCAEFC2A4Q26800231-EDC456AD-D856-445B-9F56-A1CDE17C7686Q26853509-A02E7409-2ED8-4FBF-B14A-D7BA46F39D2EQ27013811-AB4F6E0B-8E5A-4557-9125-3451E0E5B579Q27021818-76BF592A-CCCC-4E4A-8F15-BD5A81AB2CD3Q27022694-6D7FA3C7-CD70-4AD5-8D2D-DC660A299E6AQ27325843-6B83F4C0-4E6D-4057-B9EF-70669D4B693BQ27648916-9C48BC96-EA80-49CD-B10A-A8DDE34B9CC6Q28115262-C676B47D-A704-4FFC-BDF7-9BD7C7E8C0BEQ28216363-02997CA9-58C6-4CD2-A93A-1E2E6C7182DEQ28216404-035A5E0C-223E-480A-8A4D-5CE85CA235EAQ28255422-FE74BFEB-326A-4FAA-ACED-8BCAF9DC4B94Q28291371-E6610EB0-FD30-4115-8868-ED2F627667ABQ28344408-5B0374E2-7374-4F62-B215-49542F238C4AQ28344791-3AF89A51-A289-4169-AC27-70C77224F916Q28345088-0BA94530-5945-481E-A84D-07598943144CQ28345704-03422844-A9F9-4E03-B0F2-74AFBAC311ECQ28472669-79D82677-D795-40B3-A833-FFCFBF8AD615Q28473374-AE44BE95-B0E0-4191-9F99-5B3B224843BDQ28477096-9F74D1B1-C305-4DD5-9CE6-2FE018DE56A3
P2860
Inactivation of glycogen synthase kinase-3 beta by phosphorylation: new kinase connections in insulin and growth-factor signalling
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Inactivation of glycogen synth ...... n and growth-factor signalling
@en
Inactivation of glycogen synth ...... n and growth-factor signalling
@nl
type
label
Inactivation of glycogen synth ...... n and growth-factor signalling
@en
Inactivation of glycogen synth ...... n and growth-factor signalling
@nl
prefLabel
Inactivation of glycogen synth ...... n and growth-factor signalling
@en
Inactivation of glycogen synth ...... n and growth-factor signalling
@nl
P2093
P2860
P356
P1433
P1476
Inactivation of glycogen synth ...... n and growth-factor signalling
@en
P2093
Leighton IA
Sutherland C
P2860
P356
10.1042/BJ2960015
P407
P478
296 ( Pt 1)
P577
1993-11-01T00:00:00Z